EDAP TMS S.A. Overview
Pro stress-test →EDAP TMS is a French company specialized in focused ultrasound treatment of the prostate. The company develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. Founded in 1979, it offers flagship HIFU (High-Intensity Focused Ultrasound) devices like Focal One® for focal prostate cancer therapy and lithotripsy systems for urinary stone treatment.
Strategic Profile
Pro stress-test →With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. The company is further committed to developing treatments for more disorders in many organs. The company operates globally through a network of subsidiaries and distributors, serving hospitals and urology clinics worldwide.
Competitive Landscape
Pro stress-test →EDAP TMS (NASDAQ: EDAP) is the global leader in therapeutic ultrasound. The company competes in the minimally-invasive urology medical device market against larger diversified device manufacturers offering prostate treatment alternatives (radiation, surgery, hormone therapy). EDAP's differentiation lies in its integrated ultrasound platform combining diagnostics and focal therapy, though competitive pressures exist from other HIFU developers and established urology device makers.
Industry Context
EDAP TMS S.A. operates in Medical Devices - Urology / Therapeutic Ultrasound.
Key facts
Founded: 1979 · Headquarters: Vaulx-en-Velin, France · Employees: 200